Cargando…
Chemoinformatic Analysis of Psychotropic and Antihistaminic Drugs in the Light of Experimental Anti-SARS-CoV-2 Activities
INTRODUCTION: There is an urgent need to identify therapies that prevent SARS-CoV-2 infection and improve the outcome of COVID-19 patients. OBJECTIVE: Based upon clinical observations, we proposed that some psychotropic and antihistaminic drugs could protect psychiatric patients from SARS-CoV-2 infe...
Autores principales: | Villoutreix, Bruno O, Krishnamoorthy, Rajagopal, Tamouza, Ryad, Leboyer, Marion, Beaune, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051956/ https://www.ncbi.nlm.nih.gov/pubmed/33880039 http://dx.doi.org/10.2147/AABC.S304649 |
Ejemplares similares
-
Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders
por: Villoutreix, Bruno O., et al.
Publicado: (2020) -
Understanding the genetic contribution of the human leukocyte antigen system to common major psychiatric disorders in a world pandemic context
por: Tamouza, Ryad, et al.
Publicado: (2021) -
Antihistamine and cationic amphiphilic drugs, old molecules as new tools against the COVID-19?
por: Gitahy Falcao Faria, Clara, et al.
Publicado: (2021) -
The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies
por: Ellul, Pierre, et al.
Publicado: (2017) -
A double amino-acid change in the HLA-A peptide-binding groove is associated with response to psychotropic treatment in patients with schizophrenia
por: Le Clerc, S, et al.
Publicado: (2015)